会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • PROCESS FOR PREPARING PRECUT FAT OR OIL FOOD IN WATER-IN-OIL TYPE EMULSION FORM AND APPARATUS THEREFOR
    • 油脂类型乳液形式的预处理油脂的制备方法及其设备
    • WO1996029859A1
    • 1996-10-03
    • PCT/JP1996000607
    • 1996-03-12
    • SNOW BRAND MILK PRODUCTS CO., LTD.OKAMOTO, KiyotakaHONDA, YoshihikoMURAKAMI, MotoiONIKI, ShigeruSUZUKI, Koji
    • SNOW BRAND MILK PRODUCTS CO., LTD.
    • A01J23/00
    • A23D7/04A01J21/00A01J23/00A23P30/10
    • Conventional fat or oil foods in water-in-oil type emulsion form are fluid immediately after the preparation, but become very hard upon cooling. This necessitates preheating before the division of the foods, resulting in poor working efficiency and, even when the remaining portion is again cooled and stored, the deterioration in quality is unavoidable because the surface and the other portion have been melted. All the above problems have now been solved by filling a fat or oil food in fluid water-in-oil type emulsion form into a mold with a partitioning frame consisting of a plurality of partitioning plates provided therein, moving the filled food from a filling position to a discharging position, and extruding and discharging the food from the mold by means of an extruding die which has been partitioned into the same configuration as the partitioning frame and has grooves for entrance of the partitioning plates, thereby precutting the food.
    • 油包水型乳液形式的常规脂肪或油性食品在制备后立即是流体,但在冷却时变得非常困难。 这在食品分配之前需要预热,导致差的工作效率,并且即使剩余部分再次被冷却和储存,质量的劣化也是不可避免的,因为表面和其它部分已经熔化。 所有上述问题现在已经通过将脂肪或油性食品以流体油包水型乳液形式填充到具有由设置在其中的多个分隔板组成的分隔框架的模具中来解决,将填充的食物从填充位置移动 到达排出位置,并且通过已经被分隔成与分隔框架相同的构造的挤压模具从模具中挤出和排出食物,并具有用于分隔板的入口的槽,从而预先切割食物。
    • 8. 发明申请
    • MODIFIED WHEY PROTEIN
    • 改良的蛋白质
    • WO1997001964A1
    • 1997-01-23
    • PCT/JP1995002552
    • 1995-12-13
    • SNOW BRAND MILK PRODUCTS CO., LTD.IMAI, HiroshiSATO, KaoruHORIKAWA, MasakazuKAWANARI, Masami
    • SNOW BRAND MILK PRODUCTS CO., LTD.
    • A23J03/08
    • A23C15/16A23J3/08
    • A modified whey protein powder having an improved solubility and comprising a partly heat-denatured whey protein and an undenatured whey protein; and a process for producing a modified whey protein powder having an improved solubility which comprises adding an undenatured whey protein to a solution of a partly heat-denatured whey protein and drying the resultant solution. From 0.2 to 10 parts by weight of the undenatured whey protein is used per part by weight of the partly heat-denatured whey protein. The obtained powder has a hydrophobicity of 50 FI/mg protein or above or an insolubility of 1 ml or below. A gel obtained from this powder has a good water retention, a high elasticity and a smooth texture, which makes it useful as a food material.
    • 一种改良的乳清蛋白粉,其具有改善的溶解度并且包含部分热变性乳清蛋白和未变性的乳清蛋白; 以及制备具有改善的溶解度的改性乳清蛋白粉末的方法,其包括将未变性的乳清蛋白加入到部分热变性乳清蛋白的溶液中并干燥所得溶液。 每份重量份的部分热变性乳清蛋白使用0.2至10重量份的未变性乳清蛋白。 得到的粉末具有50 FI / mg蛋白质或以上的疏水性或1ml以下的不溶性。 从该粉末获得的凝胶具有良好的保水性,高弹性和光滑的质感,因此可用作食品。
    • 10. 发明申请
    • THERAPEUTIC AGENT FOR DISORDER OF LIPID METABOLISM
    • 用于脂质代谢紊乱的治疗剂
    • WO1996020004A1
    • 1996-07-04
    • PCT/JP1995002707
    • 1995-12-27
    • SNOW BRAND MILK PRODUCTS CO., LTD.SHIOTA, AkiraFUJISE, NobuakiMASUNAGA, HiroakiHIGASHIO, Kanji
    • SNOW BRAND MILK PRODUCTS CO., LTD.
    • A61K38/18
    • A61K38/1833
    • The present invention relates to a therapeutic agent for treatment of disorder of lipid metabolism comprising TCF-II as an effective ingredient. The therapeutic agent of the present invention is useful for treatment of disorder of lipid metabolism caused by diabetes, endocrinological diseases, such as thyroid dysfunction and adrenal dysfunction, chronic metabolism disorder, chronic renal failure including nephrosis, uremia, cancer, dyscrasia, adverted effects of antitumor agents, gastrointestinal (including hepatic and pancreatic) impairment and so on. Hypercholesterolemia, hypolipidemia or hypo-high-density-lipoproteinemia is exemplified as a disorder of lipid metabolism. The therapeutic agent of the present invention normalizes not only hyperlipidemia but also hypolipidemia. In addition, it improves fatty liver.
    • 本发明涉及用于治疗包含TCF-II作为有效成分的脂质代谢紊乱的治疗剂。 本发明的治疗剂可用于治疗由糖尿病引起的脂质代谢异常,内分泌疾病如甲状腺功能障碍和肾上腺功能障碍,慢性代谢障碍,慢性肾功能衰竭,包括肾病,尿毒症,癌症,dyscrasia,广告效应 抗肿瘤药,胃肠(包括肝,胰腺)损伤等。 高胆固醇血症,低脂血症或低高密度脂蛋白血症被列为脂质代谢紊乱。 本发明的治疗剂不仅使高脂血症也降低血脂异常。 此外,它改善脂肪肝。